Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.43 |
| ▸ | CTSD | P07339 | 3/20 | 0.43 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.43 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.36 |
| ▸ | CASR | P41180 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 3/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 6/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5216472 | 1.00 | BACE1 (0.43) | BACE1CTSDBACE2CSNK1EOPRM1 | |
| SCHEMBL5223492 | 0.88 | OPRM1 (0.40) | BACE1OPRM1OPRD1OPRK1CASR | |
| SCHEMBL5223500 | 0.88 | OPRM1 (0.40) | BACE1OPRM1OPRD1OPRK1CASR | |
| SCHEMBL5223916 | 0.87 | SIGMAR1 (0.41) | BACE1CSNK1EOPRM1OPRD1OPRK1 | |
| SCHEMBL5223922 | 0.87 | SIGMAR1 (0.41) | BACE1CSNK1EOPRM1OPRD1OPRK1 | |
| SCHEMBL5224655 | 0.86 | CSNK1E (0.41) | BACE1CSNK1EOPRM1OPRD1OPRK1 | |
| SCHEMBL5224641 | 0.86 | CSNK1E (0.41) | BACE1CSNK1EOPRM1OPRD1OPRK1 | |
| SCHEMBL5220912 | 0.85 | REN (0.40) | BACE1CTSDCSNK1EOPRM1OPRD1 | |
| SCHEMBL5220920 | 0.85 | REN (0.40) | BACE1CTSDCSNK1EOPRM1OPRD1 | |
| SCHEMBL5219019 | 0.81 | CASR (0.41) | CTSDOPRM1OPRD1OPRK1CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567488-B1 | HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | GLAXO GROUP LTD (GB) | 2007-02-21 | — | — | EP | disclosed |